Loading clinical trials...
Loading clinical trials...
The overall research objective of this proposal is to determine the acute and chronic impact of transcranial photobiomodulation on indices of cerebral vascular health and neurocognitive function.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Texas at Arlington
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT04570085 · Alzheimer Disease
UT Arlington - Science and Engineering Innovation and Research Building
Arlington, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions